Breakthrough study: COVID-19 reactivates dormant breast cancer, triggering deadly metastasis (shown in mice). In humans, cancer survivors who got COVID had 4.5× higher cancer-related deaths—and 1.4× greater breast cancer.
https://t.co/sfqlon6EI6
A baby boy with a devastating genetic disease is thriving after becoming the first known person to receive a bespoke, CRISPR therapy-for-one, designed to correct his specific disease-causing mutation
https://t.co/x6aOBZIXy3
The vaccine against Shingles helps protect against dementia, results of a natural experiment, adding to prior evidence
"implications are profound"
New @Nature
https://t.co/NmazPQdos2
https://t.co/HnBsMQYWfT
The first woman to be awarded a Nobel Prize, the first individual to be awarded two Nobel Prizes and still today the only individual with two Nobel Prizes in two different scientific categories: Marie Skłodowska Curie.
Skłodowska Curie developed the term radioactivity, discovered the chemical elements polonium and radium and contributed to develop new cancer treatments. For her scientific dedication and remarkable breakthroughs, she was awarded the 1903 physics prize and the 1911 chemistry prize.
Learn more: https://t.co/leyjSAzeD8
#InternationalWomensDay
Aspirin may enhance the immune response against cancer metastasis in mice, according to research published in @Nature. The authors suggest that the findings could aid the development of effective anti-metastatic immunotherapies. https://t.co/DgCLXXK9Gf
🦠Científicos/as del #CSIC describen un mecanismo molecular que modifica la eficacia de la quimioterapia
🔬Un estudio muestra que cambios en el estrés osmótico de las células cancerosas pueden generar resistencia o sensibilidad a fármacos antitumorales
➡️ https://t.co/hmpD4Aci2m
Un equipo de grandes expertos en embriología de China ha obtenido ratones viables, aunque estériles, a partir de dos ratones macho, sin intervención de hembras, con la excepción de la usada para gestar el embrión obtenido. Lo cuento en @sciencemedia_es
https://t.co/uoSLbrMXjH
1. What are the benefits and risks of GLP1?
Our new study in @naturemedicine comprehensively maps all the benefits and risks of GLP-1 receptor agonists (GLP-1) (Ozempic, Wegovy, Mounjaro, Zepbound).
By @Biostayan, Taeyoung Choi and me
🧵
https://t.co/cJR8t1fZU8
Ofertamos plaza de Técnico de Laboratorio PEJ-2024-TL/SAL-GL-33015: https://t.co/Da7hiy6okf
Los interesados tienen del 14 al 27 de enero para presentar lassolicitudes. Los aspirantes deberán acceder a la aplicación CONVOCA y seguir los pasos indicados: https://t.co/4mTCL05TVT
The first @SenesceX workshop, the #CellSenescence consortium of Madrid, is now taking place in @CNIOStopCancer with a packed auditorium.
The first speaker was @mcollado_CHUS, president of our society, and after his talk he presented our society to the attendees
Gema López Pernas @Gema20_4 from @KP_twitt_llo at @CNIOStopCancer clsoes the morning session talking about the one-two punch approach to treat cancer with senolytics. #SENESCEL2024
Gema López Pernas @Gema20_4 from @KP_twitt_llo at @CNIOStopCancer clsoes the morning session talking about the one-two punch approach to treat cancer with senolytics. #SENESCEL2024
En el CCCB lab ofertamos dos ayudas para la investigación JAE-INTRO 📢📢📢
Si quieres iniciarte en la investigación en oncología molecular 🧪🧬🔬🦠, no dudes en considerar nuestro laboratorio como opción para aprender y disfrutar de la ciencia! Te esperamos 🫵🫵🫵🫵.
Una de las científicas que más dinero genera en España no recibe ni un euro por sus descubrimientos: "Estoy verdaderamente cansada y desmotivada", cuenta. "¿Por qué no se premia a los que trabajan bien? Da igual que lo hagas bien o mal” https://t.co/AIi5CPYZlu
🔬 Hablamos de la ELA tras un nuevo hallazgo que describe la causa del posible origen de la enfermedad
🗣 Charlamos con Óscar Fernández Capetillo (@KP_twitt_llo), director del Programa de Oncología Molecular y vicedirector del @CNIOStopCancer
📻👇
https://t.co/0LN9YaTN8V
🔬#CNIOStopCancer researchers provide a new hypothesis to understand the origin of amyotrophic lateral sclerosis, or #ALS. It would be triggered by a similar problem to that occurring in a group of rare diseases called ribosomopathies.